Skip to Main Content

Less than a year since Zocdoc reinvented itself as a telehealth platform in the face of the pandemic, the company is again profitable, and on Thursday announced $150 million in fresh financing to fuel its ambitions.

The company is staking its future on the buzzy promise of hybrid care. Before the pandemic, Zocdoc’s scheduling platform was a popular digital tool linking potential patients to doctors for in-person visits. As demand for face-to-face appointments plummeted in March, Zocdoc built on its fledgling experiments in telehealth with a video service that doctors on the platform could use for free to see patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!